CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79.75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Straumann sees North America stabilising, China demand improving after Q3 beat

By Reuters News

By Cian Muenster and Isabela Kruczynska

Oct 28 (Reuters) - Swiss dental implants maker Straumann STMN.S reported third-quarter sales slightly above expectations on Wednesday, helped by new product launches and growth across its main regions.

Investors are closely watching Straumann's performance in North America, where high interest rates and inflation have weighed on the dental market, and in China, where uncertainty around the next round of the country's volume-based procurement programme has clouded demand.

The group reported third-quarter revenue of 667.1 million Swiss francs ($805.1 million), compared with a Vara consensus of 662.3 million.

North American sales grew 7.5% organically in the July-September period, compared with 5.7% growth a year ago, despite continued pressure from tariffs.

CEO Guillaume Daniellot told Reuters that high interest rates were still weighing on patient demand, but said market conditions had stabilised compared with previous quarters.

"We are able ... to grow still pretty significantly thanks to the new technology that we have launched," Daniellot said, pointing to new scanner technology and the Straumann iEXCEL implant system.

Asia-Pacific sales rose 10.3%, compared to last year's 3.2% growth, with China returning to growth after several quarters affected by uncertainty around Beijing's volume-based procurement programme.

Daniellot said Chinese demand had improved as patients increasingly went ahead with treatments they had postponed while waiting for the next procurement round. He now expects the next phase of the programme to start around early 2027, later than previously anticipated, although authorities have not provided an official timetable.

The company confirmed its full-year outlook, saying it did not expect any disruption to business trends in the final quarter.

Daniellot is due to hand over as CEO to Christopher Norbye on Dec. 1.



($1 = 0.8286 Swiss francs)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.